Description

BSE announces the listing of 8000 commercial papers issued by Sharekhan Limited on private placement basis with a face value of Rs. 5 lakhs each, effective December 9, 2025.

Summary

BSE has listed new commercial papers issued by Sharekhan Limited on a private placement basis on the BSE Debt segment effective December 9, 2025. The issue consists of 8000 commercial papers with a face value of Rs. 5,00,000 each, issued at Rs. 4,91,700.26 with maturity on March 10, 2026. The securities carry credit ratings of CRISIL A1+ and ICRA A1+.

Key Points

  • Quantity: 8000 commercial papers
  • Face Value: Rs. 5,00,000 per unit
  • Issue Price: Rs. 4,91,700.26
  • Market Lot: 1
  • Scrip Code: 730722
  • Scrip ID: SL91225
  • Detail Name: SL-10-3-26-CP
  • ISIN: INE211H14AI6
  • Credit Rating: CRISIL A1+, ICRA A1+
  • Trading in dematerialized form only
  • Standard denomination: Rs. 5 lakhs and multiples
  • Tick size: 1 paise
  • Issuing and Paying Agent: HDFC Bank Limited

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification for debt securities.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE211H14AI6
  • Trading must be conducted in standard denomination of Rs. 5 lakhs and multiples thereof
  • Trading members requiring clarification may contact the debt department at specified phone numbers (22728352/8597/8995/5753/8915)

Important Dates

  • Notice Date: December 9, 2025
  • Date of Allotment: December 9, 2025
  • Listing Date: December 9, 2025
  • Date of Redemption: March 10, 2026

Impact Assessment

This is a routine commercial paper listing in the debt segment with minimal market impact. The listing provides Sharekhan Limited with short-term financing for approximately 3 months. The strong credit ratings (CRISIL A1+ and ICRA A1+) indicate high creditworthiness. There is no impact on equity trading or broader market operations. The listing is relevant primarily for debt market participants and institutional investors dealing in commercial papers.

Impact Justification

Routine commercial paper listing on debt segment with no impact on equity markets or broad regulatory changes